Faes Farma, S.A.
17 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. (NCT06176560) | Faes Farma, S.A. | 2024-03-01 |
| Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids (NCT05788497) | Faes Farma, S.A. | 2023-03-30 |
| Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children (NCT04810390) | Faes Farma, S.A. | 2021-03-26 |
| Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency (NCT04735926) | Faes Farma, S.A. | 2020-12-23 |
| A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. (NCT03479307) | Faes Farma, S.A. | 2018-04-07 |
Track Faes Farma, S.A. automatically
Every clearance here is in the API, with alerts when new ones post.